Navigation Links
Commercialization of nanotechnology

  • Dr Greg Smith, founder of SciVentures, an early stage venture capital investor who is keen to see passion in the eyes of his investees;
  • Dr. Paul McCormack, CEO of Perth based Advanced Nanotechnology, on the experience of taking nanotechnology research from the laboratory at the University of Western Australia to a listing on the Australian Stock exchange;
  • Dr Calum Drummond, Chief of the Division of Materials Science and Engineering at the Australia Government laboratory CSIRO, on the process of spinning out knowledge and IP from CSIRO into CAP-XX, a world leading producer of super capacitors;
  • Dr John Kapeleris, Deputy CEO of the Australian Institute of Commercialisation on ways nanotechnology commercialisation can be supported; and
  • Ms Tina Rankovic, CEO of the Australian Nano Business Forum, on the outlook for the nanotechnology industry in Australia.
  • Click here to listen to the podcast in full


    Contact: Ian Birkby

    Page: 1 2

    Related biology technology :

    1. Isis Enters Broad Collaboration With Ortho-McNeil, Inc. for the Discovery, Development and Commercialization of Antisense Drugs to Treat Metabolic Diseases
    2. Keryx Biopharmaceuticals, Inc. Enters into Licensing Agreement with Japan Tobacco and Torii Pharmaceutical for Development and Commercialization of Hyperphosphatemia Drug in Japan
    3. ADVENTRX Appoints Vice President of Commercialization
    4. Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM)
    5. Product Development Timelines and Commercialization Strategy Are Focus of New Group at Premier Research
    6. Stevens to host Nanoscience/Nanotechnology & Corrosion symposium, Nov. 13
    7. NASA technology forms the basis for a new nanotechnology company
    8. Superbugs, shapes and nanotechnology
    9. Siemens and Xintek Form Joint Venture to Develop Nanotechnology-Enabled Multi-Pixel X-ray Tubes
    Post Your Comments:
    (Date:6/27/2016)... GUELPH, ON , June 27, 2016 /PRNewswire/ - BIOREM ... it has been advised by its major shareholders, Clean ... LP, United States based venture ... common shares of Biorem (on a fully diluted, as ... for the disposition of their entire equity holdings in ...
    (Date:6/27/2016)... , ... June 27, 2016 , ... Parallel 6 ... trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module which ... with the physician and clinical trial team. , Using the CONSULT module, patients and ...
    (Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
    (Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
    Breaking Biology Technology:
    (Date:6/20/2016)... 2016 Securus Technologies, a leading provider ... public safety, investigation, corrections and monitoring announced that ... has secured the final acceptance by all three ... Access Systems (MAS) installed. Furthermore, Securus will have ... installed by October, 2016. MAS distinguishes between legitimate ...
    (Date:6/7/2016)... TORONTO , June 7, 2016  Syngrafii ... begun a business relationship that includes integrating Syngrafii,s ... pilot branch project. This collaboration will result in ... for the credit union, while maintaining existing document ... ...
    (Date:6/1/2016)... YORK , June 1, 2016 ... Technology in Election Administration and Criminal Identification to Boost ... to a recently released TechSci Research report, " Global ... By Region, Competition Forecast and Opportunities, 2011 - 2021", ... 24.8 billion by 2021, on account of growing security ...
    Breaking Biology News(10 mins):